Pacific Biosciences Of California Shares Outstanding 2009-2019 | PACB
Pacific Biosciences Of California shares outstanding from 2009 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Pacific Biosciences Of California Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2018 | 135 |
| 2017 | 106 |
| 2016 | 89 |
| 2015 | 76 |
| 2014 | 70 |
| 2013 | 63 |
| 2012 | 56 |
| 2011 | 54 |
| 2010 | 10 |
| 2009 | 1 |
| 2008 | 0 |
| 2007 | 0 |
| Pacific Biosciences Of California Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| Q1 2019 | 151 |
| Q4 2018 | 135 |
| Q3 2018 | 135 |
| Q2 2018 | 132 |
| Q1 2018 | 124 |
| Q4 2017 | 106 |
| Q3 2017 | 116 |
| Q2 2017 | 97 |
| Q1 2017 | 93 |
| Q4 2016 | 89 |
| Q3 2016 | 92 |
| Q2 2016 | 88 |
| Q1 2016 | 84 |
| Q4 2015 | 76 |
| Q3 2015 | 80 |
| Q2 2015 | 75 |
| Q1 2015 | 74 |
| Q4 2014 | 70 |
| Q3 2014 | 71 |
| Q2 2014 | 71 |
| Q1 2014 | 68 |
| Q4 2013 | 63 |
| Q3 2013 | 66 |
| Q2 2013 | 62 |
| Q1 2013 | 57 |
| Q4 2012 | 56 |
| Q3 2012 | 56 |
| Q2 2012 | 56 |
| Q1 2012 | 55 |
| Q4 2011 | 54 |
| Q3 2011 | 54 |
| Q2 2011 | 53 |
| Q1 2011 | 53 |
| Q4 2010 | 10 |
| Q3 2010 | 1 |
| Q2 2010 | 1 |
| Q1 2010 | 1 |
| Q4 2009 | |
| Q3 2009 | 1 |
| Q4 2008 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.896B | $0.079B |
| Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $114.795B | 25.11 |
| Intuitive Surgical (ISRG) | United States | $60.437B | 55.69 |
| Edwards Lifesciences (EW) | United States | $39.565B | 39.53 |
| IDEXX Laboratories (IDXX) | United States | $24.500B | 64.27 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $23.376B | 15.36 |
| Teleflex (TFX) | United States | $15.415B | 33.40 |
| Olympus (OCPNY) | Japan | $14.976B | 112.05 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.611B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $14.124B | 38.08 |
| DexCom (DXCM) | United States | $13.436B | 263.52 |
| Hologic (HOLX) | United States | $12.689B | 20.41 |
| STERIS (STE) | Ireland | $12.500B | 30.23 |
| Varian Medical Systems (VAR) | United States | $12.264B | 31.29 |
| ABIOMED (ABMD) | United States | $11.776B | 71.64 |
| Masimo (MASI) | United States | $8.149B | 49.93 |
| Penumbra (PEN) | United States | $6.046B | 255.96 |
| SARTORIUS AG (SARTF) | Germany | $5.850B | 53.60 |
| Elekta AB (EKTAY) | Sweden | $5.013B | 37.78 |
| Integra LifeSciences Holdings (IART) | United States | $4.611B | 21.66 |
| Globus Medical (GMED) | United States | $4.211B | 26.26 |
| Tandem Diabetes Care (TNDM) | United States | $3.649B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.575B | 23.30 |
| Wright Medical Group (WMGI) | Netherlands | $3.346B | 663.25 |
| Cantel Medical (CMD) | United States | $3.304B | 33.52 |
| Glaukos (GKOS) | United States | $2.794B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.633B | 19.40 |
| Nihon Kohden (NHNKY) | Japan | $2.397B | 24.11 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.909B | 30.21 |
| Nevro (NVRO) | United States | $1.896B | 0.00 |
| Inogen (INGN) | United States | $1.313B | 29.07 |
| OPKO Health (OPK) | United States | $1.299B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.262B | 0.00 |
| Veracyte (VCYT) | United States | $1.208B | 0.00 |
| CryoLife (CRY) | United States | $1.122B | 111.33 |
| Accelerate Diagnostics (AXDX) | United States | $1.039B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.019B | 150.31 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.975B | 28.24 |
| Mesa Laboratories (MLAB) | United States | $0.902B | 42.40 |
| Luminex (LMNX) | United States | $0.899B | 117.53 |
| ViewRay (VRAY) | United States | $0.896B | 0.00 |
| Natus Medical (BABY) | United States | $0.877B | 20.31 |
| AngioDynamics (ANGO) | United States | $0.802B | 26.27 |
| AxoGen (AXGN) | United States | $0.787B | 0.00 |
| Fluidigm (FLDM) | United States | $0.780B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.696B | 0.00 |
| Intersect ENT (XENT) | United States | $0.634B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.542B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.531B | 0.00 |
| Si-Bone (SIBN) | United States | $0.493B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.358B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.344B | 18.44 |
| Accuray (ARAY) | United States | $0.320B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.307B | 37.82 |
| Semler Scientific (SMLR) | United States | $0.304B | 60.26 |
| TransEnterix (TRXC) | United States | $0.296B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.240B | 0.00 |
| Neuronetics (STIM) | United States | $0.234B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.220B | 0.00 |
| ConforMIS (CFMS) | United States | $0.216B | 0.00 |
| IRadimed (IRMD) | United States | $0.206B | 39.19 |
| CRH Medical (CRHM) | Canada | $0.201B | 69.75 |
| Sientra (SIEN) | United States | $0.184B | 0.00 |
| Stereotaxis (STXS) | United States | $0.170B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.107B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.089B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.086B | 0.00 |
| Vermillion (VRML) | United States | $0.082B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.077B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.076B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.066B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.064B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.053B | 0.00 |
